伴腋窝淋巴结寡转移的晚期胸腺肠型腺癌1例
Advanced Enteric-type Thymic Adenocarcinoma with Axillary Lymph Node Oligometastasis:A Case Report
摘要
胸腺肠型腺癌(enteric-type thymic adenocarcinoma,ETAC)是胸腺癌的一种罕见亚型,其组织学和免疫表型与肠道腺癌高度相似,易误诊为消化道转移癌.本文报道1例伴腋窝淋巴结寡转移的晚期ETAC患者,经正电子发射断层显像/计算机断层扫描(positron emission tomography/computed tomography,PET/CT)及胃肠镜排除消化道原发肿瘤,患者接受正中开胸胸腺扩大切除术,有效缓解上腔静脉梗阻与心肺压迫症状,术后行全身化疗联合免疫治疗,以及针对原发瘤床和转移淋巴结的区域放疗.术后随访24个月未见疾病进展.本例表明对于伴有寡转移的晚期ETAC患者,积极的局部治疗联合基于分子分型的全身治疗有可能为部分经过严格选择的寡转移患者提供新的治疗机会.
Enteric-type thymic adenocarcinoma(ETAC)is a rare subtype of thymic carcinoma.It shares highly similar histological and immunophenotypic features with intestinal adenocarcinoma,and is therefore prone to being misdi-agnosed as metastatic carcinoma of gastrointestinal origin.Herein,we report a case of advanced ETAC with axillary lymph node oligometastasis.Positron emission tomography/computed tomography(PET/CT)and gastrointestinal endoscopy were performed to rule out primary gastrointestinal malignancy.The patient underwent median sternotomy with extended thymec-tomy,which effectively relieved superior vena cava obstruction and cardiopulmonary compressive symptoms.Postoperatively,systemic chemotherapy combined with immunotherapy,as well as regional radiotherapy targeting the primary tumor bed and metastatic lymph nodes,were administered.The patient remained disease-free during the 24-month postoperative follow-up.This case suggests that aggressive local therapy combined with molecular-subtype-based systemic treatment may offer novel therapeutic opportunities for carefully selected patients with advanced ETAC and oligometastases.
年,卷(期):
2026, 29(8)
机标分类号:
R737.9
TP393
U464
在线出版日期:
2026年10月29日